Abstract
NF-κB/Rel transcription factors are modulators of immune and inflammatory processes and are also involved in malignancy. Phosphorylation of the IκB inhibitors by the IκB kinase (IKK) complex leads to their proteasomal degradation, resulting in activated NF-κB. Here, we investigated the activation status of NF-κB and the IKK complex in acute myeloid leukemia (AML). Gelshift assays revealed an increased level of activated nuclear NF-κB in myeloid blasts. Both bone marrow and peripheral blood blasts from AML patients showed enhanced IKK activity relative to controls, whereas the IKK protein concentrations were comparable. In addition, an increased level of IκB-α was detected in AML blast cells, although this appeared to be insufficient to block nuclear translocation of NF-κB, also confirmed by immunofluorescence. In subtype M4 and M5 AML cells a more extensive NF-κB activation and higher IKK activity was found than in M1/M2 specimens. Isolated AML blasts cultured ex vivoresponded to external stimulation (TNF, LPS) by further IKK activation, IκB degradation and NF-κB activation. Preincubation with the proteasome inhibitor PSI inhibited the NF-κB system in isolated AML blasts. This study established for the first time a dysregulation of IKK signaling in AML leading to increased NF-κB activity suggesting potential therapeutic avenues.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Baeuerle PA, Baltimore D . NF-κB: ten years after Cell 1996 87: 13–20
Thanos D, Maniatis T . NF-κB: a lesson in family values Cell 1995 80: 529–532
Brand K, Page S, Walli AK, Neumeier D, Baeuerle PA . Role of nuclear factor-κB in atherogenesis Exp Physiol 1997 82: 297–304
Mayo MW, Baldwin AS . The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance Biochim Biophys Acta 2000 1470: M55–M62
Bargou RC, Leng C, Krappmann D, Emmerich F, Mapara MY, Bommert K, Royer HD, Scheidereit C, Dörken B . High-level nuclear NF-κB and Oct-2 is a common feature of cultured Hodgkin/Reed-Sternberg cells Blood 1996 87: 4340–4347
Kordes U, Krappmann D, Heissmeyer V, Ludwig WD, Scheidereit C . Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells Leukemia 2000 14: 399–402
Whiteside ST, Israel A . I kappa B proteins: structure, function and regulation Semin Cancer Biol 1997 8: 75–82
May MJ, Ghosh S . Rel/NF-kappaB and I kappa B proteins: an overview Semin Cancer Biol 1997 8: 63–73
Wulczyn FG, Krappmann D, Scheidereit C . The NF-κB/Rel and IκB gene families: mediators of immune response and inflammation J Mol Med 1996 74: 749–769
Rayet B, Gelinas C . Aberrant rel/nfkb genes and activity in human cancer Oncogene 1999 18: 6938–6947
Brand K, Eisele T, Kreusel U, Page M, Page S, Haas M, Gerling A, Kaltschmidt C, Neumann FJ, Mackman N, Baeuerle PA, Walli AK, Neumeier D . Dysregulation of monocytic nuclear factor-κB by oxidized low-density lipoprotein Arterioscler Thromb Vasc Biol 1997 17: 1901–1909
Page S, Fischer C, Baumgartner B, Haas M, Kreusel U, Loidl G, Hayn M, Ziegler-Heitbrock HWL, Neumeier D, Brand K . 4-Hydroxynonenal prevents NF-κB activation and TNF expression by inhibiting IκB phosphorylation and subsequent proteolysis J Biol Chem 1999 274: 11611–11618
Mackman N, Brand K, Edgington TS . Lipopolysaccharide-mediated transcriptional activation of human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites J Exp Med 1991 174: 1517–1526
Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-κB activity Annu Rev Immunol 2000 18: 621–663
Israel A . The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol 2000 10: 129–133
Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV . IkappaB kinase-beta: NF-kappaB activation and complex formation with IkappaB kinase-alpha and NIK Science 1997 278: 866–869
Fischer C, Page S, Weber M, Eisele T, Neumeier D, Brand K . Different effects of LPS and TNF on monocytic IKK signalsome activation and IκB proteolysis J Biol Chem 1999 274: 24625–24632
Krappmann D, Emmerich F, Kordes U, Scharschmidt E, Dörken B, Scheidereit C . Molecular mechanisms of constitutive NF-κB/Rel activation in Hodgkin/Reed–Sternberg cells Oncogene 1999 18: 943–953
Sun SC, Ballard DW . Persistent activation of NF-kappaB by the tax transforming protein of HTLV-1: hijacking cellular IkappaB kinases Oncogene 1999 18: 6948–6958
Dokter WHA, Tuyt L, Sierdsema SJ, Esselink MT, Vellenga E . The spontaneous expression of interleukin-1β and interleukin-6 is associated with spontaneous expression of AP-1 and NF-κB transcription factor in acute myeloblastic leukemia cells Leukemia 1995 9: 425–432
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C . Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French–American–British Cooperative Group Ann Intern Med 1985 103: 620–625
McKenna RW . Multifaceted approach to the diagnosis and classification of acute leukemias Clin Chem 2000 46: 1252–1259
Brand K, Page S, Rogler G, Bartsch A, Brandl R, Knuechel R, Page M, Kaltschmidt C, Baeuerle PA, Neumeier D . Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion J Clin Invest 1996 97: 1715–1722
Brand K, Mackman N, Curtiss LK . Interferon-γ inhibits macrophage apolipoprotein E production by posttranslational mechanisms J Clin Invest 1993 91: 2031–2039
O'Byrne KJ, Dalgleish AG, Browning MJ, Steward WP, Harris AL . The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease Eur J Cancer 2000 36: 151–169
Barkett M, Gilmore TD . Control of apoptosis by Rel/NF-κB transcription factors Oncogene 1999 18: 6910–6924
Wuchter C, Krappmann D, Cai Z, Ruppert V, Scheidereit C, Dörken B, Ludwig W-D, Karawajew L . In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-κB activity Leukemia 2001 15: 921–928
Guzman ML, Neering SJ, Upchurch D, Grimes B, Howard DS, Rizzieri DA, Luger SM, Jordan CT . Nuclear factor-κB is constitutively activated in primitive human acute myelogenous leukemia cells Blood 2001 98: 2301–2307
Mori N, Fujii M, Ikeda S, Yamada Y, Tomonaga M, Ballard DW, Yamamoto N . Constitutive activation of NF-kappa B in primary adult T-cell leukemia cells Blood 1999 93: 2360–2368
Seeger C, Mason WS . Hepatitis B virus biology Microbiol Mol Biol Rev 2000 64: 51–68
Asaka M, Takeda H, Sugiyama T, Kato M . What role does Helicobacter pylori play in gastric cancer? Gastroenterology 1997 113: 56–60
Wood KM, Roff M, Hay RT . Defective IκBα in Hodgkin cell lines with constitutively active NF-κB Oncogene 1998 16: 2131–2139
Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC . Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases Mol Cell Biol 1998 18: 5157–5165
Devalaraja MN, Wang DZ, Ballard DW, Richmond A . Elevated constitutive IκB kinase activity and IκB-α phosphorylation in Hs294T melanoma cells lead to increased basal MGSA/GRO-α transcription Cancer Res 1999 59: 1372–1377
Arsura M, Mercurio F, Oliver AL, Thorgeirsson SS, Sonenshein GE . Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells Mol Cell Biol 2000 20: 5381–5391
Greer JP, Baer MR, Kinney MC . Acute myelogenous leukemia In: Lee G, Foerster J, Lukens J, Paraskevas F, Rodgers G (eds) Wintrobe's Clinical Hematology, 10th edn Lippincott Williams & Wilkins: Philadelphia 1998 pp 2272–2319
Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K . Establishment and characterization of a human acute monocytic leukemia cell line (THP-1) Int J Cancer 1980 26: 171–176
Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer RD, Grinstein E, Greiner A, Scheidereit C, Dörken B . Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin‘s disease tumor cells J Clin Invest 1997 100: 2961–2969
Cogswell PC, Guttridge DC, Funkhouser WK, Baldwin AS Jr . Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 Oncogene 2000 19: 1123–1131
Emmerich F, Meiser M, Hummel M, Demel G, Foss HD, Jundt F, Mathas S, Krappmann D, Scheidereit C, Stein H, Dörken B . Overexpression of I kappa B alpha without inhibition of NF-kappaB activity and mutations in the I kappa B alpha gene in Reed–Sternberg cells Blood 1999 94: 3129–3134
Baichwal VR, Baeuerle PA . Apoptosis: Activate NF-κB or die? Curr Biol 1997 7: R94–R96
Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM . Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells Blood 1998 91: 4624–4631
Romano MF, Lamberti A, Bisogni R, Tassone P, Pagnini D, Storti G, Del Vecchio L, Turco MC, Venuta S . Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-kappa B/Rel-specific decoy oligodeoxynucleotides Gene Ther 2000 7: 1234–1237
May MJ, D'Acquisto F, Madge LA, Glockner J, Pober JS, Ghosh S . Selective inhibition of NF-κB activation by a peptide that blocks the interaction of NEMO with the IκB kinase complex Science 2000 289: 1550–1554
Estrov Z, Manna SK, Harris D, Van Q, Estey EH, Kantarjian HM, Talpaz M, Aggarwal BB . Phenylarsine oxide blocks interleukin-1β-induced activation of the nuclear transcription factor NF-κB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells Blood 1999 94: 2844–2853
Burnett AK, Eden OB . The treatment of acute leukemia Lancet 1997 349: 270–275
Acknowledgements
Special thanks to Tamara Eisele for excellent technical assistance as well as to Margit Obst, Marion Barchfeld and Doris Schmidbauer from the hematological laboratory of the Institute of Clinical Chemistry and Pathobiochemistry for their support during this project. We also thank Michael Henning from the Institute for Medical Statistics and Epidemiology, Klinikum rechts der Isar, Technische Universität München, for help with the statistical analyses. This work was supported by the Deutsche Forschungsgemeinschaft (Br 1026/3-3) and by the Medical Faculty of the Technische Universität München (H 50-98).
Author information
Authors and Affiliations
Corresponding author
Additional information
In memory of Maria Brand-Bartsch who died from AML.
Rights and permissions
About this article
Cite this article
Baumgartner, B., Weber, M., Quirling, M. et al. Increased IκB kinase activity is associated with activated NF-κB in acute myeloid blasts. Leukemia 16, 2062–2071 (2002). https://doi.org/10.1038/sj.leu.2402641
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402641
Keywords
This article is cited by
-
PHF6 maintains acute myeloid leukemia via regulating NF-κB signaling pathway
Leukemia (2023)
-
LILRB4 signalling in leukaemia cells mediates T cell suppression and tumour infiltration
Nature (2018)
-
NF-κB/STAT5/miR-155 network targets PU.1 in FLT3-ITD-driven acute myeloid leukemia
Leukemia (2015)
-
NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death
BMC Complementary and Alternative Medicine (2012)
-
Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia
International Journal of Hematology (2012)